Detailed information for compound 414962

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 324.357 | Formula: C17H18N5O2+
  • H donors: 3 H acceptors: 4 LogP: 2.5 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: C[NH+](CCNc1ccc2c3c1c(=O)c1cc(O)ccc1n3nn2)C
  • InChi: 1S/C17H17N5O2/c1-21(2)8-7-18-12-4-5-13-16-15(12)17(24)11-9-10(23)3-6-14(11)22(16)20-19-13/h3-6,9,18,23H,7-8H2,1-2H3/p+1
  • InChiKey: OMSFZBMJHQNEQZ-UHFFFAOYSA-O  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Loa Loa (eye worm) hypothetical protein 0.013 0.3248 0.8921
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma cruzi DNA polymerase eta, putative 0.0054 0.1192 1
Schistosoma mansoni hypothetical protein 0.0019 0.024 0.0919
Giardia lamblia NADPH oxidoreductase, putative 0.0024 0.0376 0.651
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma cruzi flap endonuclease-1 (FEN-1), putative 0.0031 0.0577 0.4843
Entamoeba histolytica Flap nuclease, putative 0.0031 0.0577 1
Mycobacterium leprae PROBABLE CATION-TRANSPORTER P-TYPE ATPASE B CTPB 0.001 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Echinococcus multilocularis dna polymerase kappa 0.0023 0.0356 0.109
Mycobacterium ulcerans DNA polymerase IV 0.0023 0.0356 1
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.1359 0.3732
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0023 0.0356 0.109
Plasmodium falciparum flap endonuclease 1 0.0031 0.0577 1
Brugia malayi Latrophilin receptor protein 2 0.0019 0.024 0.066
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Loa Loa (eye worm) hypothetical protein 0.0106 0.2614 0.7182
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Brugia malayi MH2 domain containing protein 0.0144 0.364 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0023 0.0356 0.1361
Echinococcus granulosus transcription factor eb 0.013 0.3265 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0016 0.0159 0.1337
Entamoeba histolytica deoxycytidyl transferase, putative 0.0023 0.0356 0.6167
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Schistosoma mansoni hypothetical protein 0.0019 0.024 0.0919
Brugia malayi Helix-loop-helix DNA-binding domain containing protein 0.013 0.3265 0.8968
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0023 0.0356 0.2986
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 0.1224 0.3748
Leishmania major DNA polymerase eta, putative 0.0054 0.1192 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis FMN-dependent NADH-azoreductase, putative 0.0024 0.0376 0.0376
Echinococcus multilocularis flap endonuclease 1 0.0031 0.0577 0.1768
Entamoeba histolytica iron-sulfur flavoprotein, putative 0.0024 0.0376 0.651
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Schistosoma mansoni hypothetical protein 0.0041 0.0841 0.3217
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.0841 0.231
Schistosoma mansoni terminal deoxycytidyl transferase 0.0023 0.0356 0.1361
Echinococcus multilocularis transcription factor eb 0.013 0.3265 1
Schistosoma mansoni hypothetical protein 0.0019 0.024 0.0919
Echinococcus granulosus GPCR family 2 0.0019 0.024 0.0736
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 0.1224 0.3748
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.1359 0.3732
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0356 0.2986
Schistosoma mansoni hypothetical protein 0.0019 0.024 0.0919
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Brugia malayi hypothetical protein 0.0106 0.2614 0.7182
Giardia lamblia DINP protein human, muc B family 0.0023 0.0356 0.6167
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.1224 0.4681
Brugia malayi ImpB/MucB/SamB family protein 0.0023 0.0356 0.0978
Trypanosoma brucei flap endonuclease-1 (FEN-1), putative 0.0031 0.0577 0.4843
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0019 0.024 0.0736
Trichomonas vaginalis flap endonuclease-1, putative 0.0031 0.0577 0.0577
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0356 0.2986
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0023 0.0356 0.0356
Loa Loa (eye worm) hypothetical protein 0.0106 0.2614 0.7182
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0023 0.0356 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Mycobacterium leprae PROBABLE CATION-TRANSPORTER ATPASE I CTPI 0.001 0 0.5
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Schistosoma mansoni eyes absent homolog 0.0106 0.2614 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 0.1224 0.3748
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0019 0.024 0.0736
Brugia malayi Flap endonuclease-1 0.0031 0.0577 0.1586
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Treponema pallidum cation-transporting ATPase, P-type 0.001 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0016 0.0159 0.1337
Brugia malayi ImpB/MucB/SamB family protein 0.0054 0.1192 0.3274
Chlamydia trachomatis metal transport ATPase 0.001 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0041 0.0841 0.231
Treponema pallidum hypothetical protein 0.001 0 0.5
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0024 0.0376 0.0376
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Loa Loa (eye worm) hypothetical protein 0.0019 0.024 0.066
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0019 0.024 0.0736
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0019 0.024 0.066
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0055 0.1224 0.3361
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0023 0.0356 0.0978
Entamoeba histolytica modulator of drug activity B homolog, putative 0.0024 0.0376 0.651
Leishmania major flap endonuclease-1 (FEN-1), putative 0.0031 0.0577 0.4843
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Echinococcus granulosus dna polymerase kappa 0.0023 0.0356 0.109
Giardia lamblia NADPH oxidoreductase, putative 0.0024 0.0376 0.651
Echinococcus multilocularis GPCR, family 2 0.0019 0.024 0.0736
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.1224 0.4681
Giardia lamblia Flap structure-specific endonuclease 0.0031 0.0577 1
Leishmania major DNA polymerase eta, putative 0.0038 0.0755 0.6336
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trypanosoma brucei unspecified product 0.0023 0.0356 0.2986
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 0.1224 0.3748
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Loa Loa (eye worm) latrophilin receptor protein 2 0.0019 0.024 0.066
Mycobacterium leprae Probable metal cation-transporting P-type ATPase C CtpC 0.001 0 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0356 0.2986
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.364 1
Trichomonas vaginalis DNA polymerase eta, putative 0.0023 0.0356 0.0356
Loa Loa (eye worm) helix-loop-helix DNA-binding domain-containing protein 0.013 0.3248 0.8921
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0019 0.024 0.0736
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0378 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.1224 0.4681
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.364 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.1359 0.3732
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Loa Loa (eye worm) flap endonuclease-1 0.0031 0.0577 0.1586
Mycobacterium ulcerans DNA polymerase IV 0.0023 0.0356 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.0023 0.0356 1
Schistosoma mansoni flap endonuclease-1 0.0028 0.0495 0.1894
Echinococcus granulosus dna polymerase eta 0.0054 0.1192 0.3651
Loa Loa (eye worm) hypothetical protein 0.006 0.1359 0.3732
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Loa Loa (eye worm) hypothetical protein 0.0054 0.1192 0.3274
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma brucei unspecified product 0.0016 0.0159 0.1337
Entamoeba histolytica hypothetical protein 0.0024 0.0376 0.651
Trypanosoma brucei DNA polymerase kappa, putative 0.0016 0.0159 0.1337
Onchocerca volvulus 0.001 0 0.5
Leishmania major DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Toxoplasma gondii flap structure-specific endonuclease 1, putative 0.0031 0.0577 0.7644
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0055 0.1224 0.3361
Trypanosoma cruzi DNA polymerase eta, putative 0.0038 0.0755 0.6336
Plasmodium vivax flap endonuclease 1, putative 0.0031 0.0577 1
Toxoplasma gondii ImpB/MucB/SamB family protein 0.0038 0.0755 1
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0023 0.0356 0.109
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma brucei unspecified product 0.0016 0.0159 0.1337
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Echinococcus granulosus flap endonuclease 1 0.0031 0.0577 0.1768
Giardia lamblia NADPH oxidoreductase, putative 0.0024 0.0376 0.651
Trypanosoma brucei DNA polymerase eta, putative 0.0054 0.1192 1
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trichomonas vaginalis conserved hypothetical protein 0.0024 0.0376 0.0376
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Echinococcus multilocularis dna polymerase eta 0.0054 0.1192 0.3651
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0356 0.2986
Trichomonas vaginalis modulator of drug activity B, putative 0.0024 0.0376 0.0376
Schistosoma mansoni DNA polymerase eta 0.0054 0.1192 0.4559

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.7 uM Inihibition of human recombinant NQO1 ChEMBL. 17011189

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.